Search Results - "van Lith SAM"

CAIX-targeted α therapy directed against hypoxic tumor cells in combination with immune checkpoint inhibitors in a syngeneic mouse tumor model.

Authors: Wenker STM Konijnenberg MW Lobeek D et al.

Source: Theranostics [Theranostics] 2026 Feb 11; Vol. 16 (9), pp. 4508-4520. Date of Electronic Publication: 2026 Feb 11 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

Efficacy of combined targeted radionuclide therapy and immune checkpoint Inhibition in animal tumour models: a systematic review and meta-analysis of the literature.

Authors: Kleinendorst SC Hooijmans CR Muselaers S et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2025 Oct; Vol. 52 (12), pp. 4735-4751. Date of Electronic Publication: 2025 Apr 26.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

High-yield, standardised automated radiosynthesis process for routine clinical insulinoma PET with [⁶⁸Ga]Ga-NODAGA-exendin-4.

Authors: Duray, Elodie Sacrez, Matthieu Hawotte, Marine et al.

Source: EJNMMI Radiopharmacy & Chemistry. 6/30/2026, Vol. 11 Issue 1, p1-18. 18p.

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D.

Authors: Klomp, Maria J. Erkens, Sigrun E. van den Brink, Lilian et al.

Source: EJNMMI Research. 4/3/2026, Vol. 16 Issue 1, p1-11. 11p.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors: Spreckelmeyer, S. Dasilva, J. Decristoforo, C. et al.

Source: EJNMMI Radiopharmacy & Chemistry. 3/25/2025, Vol. 10 Issue 1, p1-19. 19p.

PSMA radioligand uptake correlates with PSMA expression in high-grade glioma and brain metastasis: insights from a prospective PET-MRI guided multiregional biopsy study.

Authors: Pruis, Ilanah J. van Dis, Vera Maas, Sybren L. N. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2025, Vol. 52 Issue 13, p4870-4881. 12p.

Advances in clinical neuro-oncology research on integrin PET imaging.

Authors: Henssen, Dylan Herings, Siem Sabri, Osama et al.

Source: EJNMMI Reports. 9/29/2025, Vol. 9 Issue 1, p1-14. 14p.

Auger electron-emitting EGFR-targeted and non-targeted [¹⁹⁷Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM).

Authors: Brown, Madeline K. Cai, Zhongli Georgiou, Constantine J. et al.

Source: EJNMMI Radiopharmacy & Chemistry. 7/17/2025, Vol. 10 Issue 1, p1-20. 20p.

A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [²¹²Pb]Pb-FAPI-46.

Authors: Kristiansen, Sandra K. Dernjani, Nurtene Bruland, Øyvind S. et al.

Source: EJNMMI Radiopharmacy & Chemistry. 4/18/2026, Vol. 11 Issue 1, p1-21. 21p.

The potential of targeted radionuclide therapy to treat hypoxic tumor cells.

Authors: Wenker STM van Lith SAM Tamborino G et al.

Source: Nuclear medicine and biology [Nucl Med Biol] 2025 Jan-Feb; Vol. 140-141, pp. 108971. Date of Electronic Publication: 2024 Nov 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE

Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study).

Authors: Binzaqr, Salma Kryza, David Giraudet, Anne-Laure et al.

Source: EJNMMI Research. 4/9/2025, Vol. 15 Issue 1, p1-9. 9p.

²¹¹At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.

Authors: Levillain H Moës AR Gameiro-Paris C et al.

Corporate Authors: Levillain H Moës AR Gameiro-Paris C et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 May 29. Date of Electronic Publication: 2026 May 29.

Publication Type: Editorial

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Bispecific antibodies and nanotechnology: a strategic alliance in cancer immunotherapy.

Authors: Battistini, Elisa Lapuhs, Philipp Jiménez, Alberto et al.

Source: Molecular Cancer. 11/17/2025, Vol. 24 Issue 1, p1-19. 19p.

Imply on diagnosis and early prognosis of preoperative [⁶⁸Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.

Authors: Pełka, K. Koczyk, K. Koperski, L. et al.

Source: Scientific Reports. 1/2/2025, Vol. 15 Issue 1, p1-13. 13p.

Preclinical evaluation and pilot clinical study of [⁶⁸Ga]Ga-NOTA-H006 for non-invasive PET imaging of 5T4 oncofetal antigen.

Authors: He, Yingfang Tian, Ruhua Xu, Dong et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2025, Vol. 52 Issue 2, p611-622. 12p.

Sterke correlatie tussen de intensiteit van prostaatkankerrecidieven op de PSMA PET/CT-scan en het intra-operatieve gammasonde signaal.

Alternate Title: Strong correlation between the intensity of prostate cancer recurrence on PSMA PET/CT and intraoperative gamma probe signal.

Authors: Berrens, Anne-Claire Sorbi, Malou A. Donswijk, Maarten L. et al.

Source: Tijdschrift voor Urologie. Dec2024, Vol. 14 Issue 8, p182-190. 9p.

May the Nuclear Medicine be with you! Neuroendocrine tumours and the return of nuclear medicine.

Authors: Ekmekcioglu, Ozgul Hughes, Simon Fendler, Wolfgang P et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2024, Vol. 52 Issue 1, p3-8. 6p.

Automated radiosynthesis of pharmaceutical grade [⁶⁸Ga]Ga-NODAGA-Lys⁴⁰-Exendin-4 and demonstration of its efficacy for use in patients.

Authors: Menon, Sreeja Raj Mitra, Arpit Chakraborty, Avik et al.

Source: Journal of Radioanalytical & Nuclear Chemistry. Aug2024, Vol. 333 Issue 8, p3873-3891. 19p.

Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand.

Authors: Derks, Yvonne H. W. Schilham, Melline G. M. Rijpkema, Mark et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 9, p2872-2884. 13p. 2 Color Photographs, 1 Diagram, 2 Graphs.

Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.

Authors: Houvast, Ruben D. Badr, Nada March, Taryn et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 8, p2179-2192. 14p.